There are 3163 resources available
606O - Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors
Presenter: Funda Meric-Bernstam
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
LBA20 - First-line carboplatin-cyclophosphamide (CC) versus paclitaxel (P) with or without atezolizumab (atezo) for metastatic triple negative breast cancer (mTNBC): Results from a multicenter, randomized phase IIb trial: The Triple-B study (BOOG 2013-01)
Presenter: Marleen Kok
Session: Proffered paper session: Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1723MO - Axitinib plus avelumab in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST) after failure of standard therapy: Single-arm phase II study (AXAGIST)
Presenter: Piotr Rutkowski
Session: Mini oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
1147MO - Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): An AIO phase II multicenter single-arm study
Presenter: Sebastian Krug
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Can we expand bladder preservation by optimal use of systemic therapy and biomarkers?
Resources:
Webcast
Q&A and discussion
Session: Lung cancer interception: New approaches to lung cancer screening and prevention
Resources:
Webcast
Q&A and discussion
Session: Personalised immunotherapy strategies for head and neck cancers
Resources:
Webcast
Q&A
Session: 9th ESMO Designated Centres of Integrated Oncology and Palliative Care session and awards: Specific considerations for integration of oncology and palliative care
Resources:
Webcast
992O - Pembrolizumab for HPV-associated recurrent respiratory papillomatosis
Presenter: Sara Pai
Session: Proffered paper session: Investigational immunotherapy
Resources:
Abstract
Webcast
607O - Interim results of a phase I study of SGN-PDL1V (PF-08046054) in patients with PDL1-expressing solid tumors
Presenter: Marc Oliva Bernal
Session: Proffered paper session 1: Developmental therapeutics
Resources:
Abstract
Slides
Webcast